7572 Phosphofructokinase C-terminal domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 5 | 5.3 | 0.94× | q = 1.00 | |
| Organic oxygen compounds | 8 | 2.2 | 3.70× | not tested | |
| Nucleosides, nucleotides, and analogues | 8 | 3.0 | 2.67× | not tested | |
| Benzenoids | 1 | 0.8 | 1.26× | not tested | |
| Organic acids and derivatives | 2 | 1.7 | 1.19× | not tested | |
| Organoheterocyclic compounds | 1 | 1.7 | 0.60× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 21 |
| DB16833 | ADP | Adenosine disphosphate | 18 |
| DB04551 | FBP | beta-D-fructofuranose 1,6-bisphosphate | 12 |
| DB01819 | PEP | Phosphoenolpyruvate | 8 |
| DB00131 | AMP | Adenosine phosphate | 7 |
| DB02726 | PGA | 2-Phosphoglycolic Acid | 4 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 1 |
| DB04522 | SEP | Dexfosfoserine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FBP | 1,6-di-O-phosphono-beta-D-fructofuranose | 40 |
| F6P | 6-O-phosphono-beta-D-fructofuranose | 39 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 37 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 31 |
| AMP | ADENOSINE MONOPHOSPHATE | 30 |
| MGmetal | MAGNESIUM ION | 14 |
| FDP | 2,6-di-O-phosphono-beta-D-fructofuranose | 8 |
| PEP | PHOSPHOENOLPYRUVATE | 8 |
| YG1 | N-{(11S)-2-[2-(5-hydroxypent-1-yn-1-yl)phenyl]-4H,10H-pyrazolo[5,1-c][1,4]benzoxazepin-7-yl}acetamide | 8 |
| CL | CHLORIDE ION | 5 |
| HSX | 5-O-phosphono-alpha-D-ribofuranose | 4 |
| JJ2 | 1-[(3,4-dichlorophenyl)methyl]-5-[2-(dimethylamino)ethyl]pyrrolo[3,2-c]pyridin-4-one | 4 |
| JJ5 | 1-[(3,4-dichlorophenyl)methyl]-7~{H}-pyrrolo[3,2-c]pyridin-4-one | 4 |
| NAmetal | SODIUM ION | 4 |
| PGA | 2-PHOSPHOGLYCOLIC ACID | 4 |
| CAmetal | CALCIUM ION | 3 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 2 |
| BG6 | 6-O-phosphono-beta-D-glucopyranose | 2 |
| G6P | 6-O-phosphono-alpha-D-glucopyranose | 2 |
| JJ8 | 1-[(3,4-dichlorophenyl)methyl]imidazole | 2 |